You have read all your free articles, to continue reading subscribe to read the rest of this content.
Hansa Medical and Axis-Shield report most promising results from pivotal clinical trial with HBP-analysis. The clinical study was carried out at Emergency Departments both in Sweden and the US through 2011-2013. Results show that HBP-analysis predicts patients with forthcoming severe inflammatoryAlready a subscriber Login You have read all your free…
The Gothenburg based company has announced that an article has been published in Neurology, from the American Academy of Neurology, describing data from the company’s IPO-001 pharmacokinetic cross-over study. In a pharmacokinetic cross-over study comprising 18 evaluable subjects with advanced PAlready a subscriber Login You have read all your free…
Three-month paliperidone palmitate, an investigational atypical antipsychotic developed by Janssen Research & Development, LLC, significantly delayed relapse time compared with a placebo in patients with schizophrenia, according to a new Phase 3 clinical study recently published in the Journal oAlready a subscriber Login You have read all your free articles,…
All participants have been included in a Phase II clinical study, DIABGAD-1, in which Diamyd Medical’s diabetes vaccine Diamyd, in a unique combination with other drugs, is tested in children and adolescents recently diagnosed with type 1 diabetes. The first results from the researcher initiateAlready a subscriber Login You have…
